Terumo Blood and Cell Technologies

📢 Building the Future of Cell & Gene Therapy in South Korea Terumo Blood and Cell Technologies is proud to partner with KBIOHealth to strengthen South Korea’s cell and gene therapy (#CGT) manufacturing workforce. Through this collaboration, we are launching GMP training programs for MSC and CAR-T therapies, equipping professionals with hands-on experience in automated manufacturing workflows using Terumo BCT’s platforms. We believe in the power of #people and #training. By investing in workforce development, we aim to advance the future of regenerative medicine—ensuring skilled professionals can meet the growing global demands for CGT manufacturing. 🔗 Learn more about our collaboration here: https://bit.ly/4idm8TD #CellTherapy #InnovationandQuality #RegenerativeMedicine #CellExpansion #MSC #CART

Cell therapy manufacturing is a delicate balance. Every step, from cell collection to final product, is crucial to success. Cell collection is often a misunderstood step in the overall cell therapy manufacturing process. A suboptimal collection process can lead to: • Delayed timelines: Missed target cell counts and processing delays • Compromised product quality: Cellular contaminants and reduced cell viability • Increased costs: Inefficient processes and potential manufacturing failures Don't let cell collection be the bottleneck in a therapy's journey. Discover how data-driven strategies and advanced technologies can optimize the collection process and help achieve the highest quality starting material. Read our new #whitepaper on the challenges, requirements, and existing solutions to obtaining optimal starting material: https://bit.ly/3QA8Qo2 #CellTherapy #Biopharma #Biotech #CellManufacturing #Apheresis #DataAnalytics #InnovationandQuality

Kick off your weekend with some inspiration! 👂🎙️ Listen to Joy Duemke and Barry Liden , President of Patient Voice Advisors, as they chat about the power of the patient voice in healthcare innovation. Big thanks to Karen Jagoda for making this happen! Link To Podcast: https://lnkd.in/g_mAUBBM #PatientAdvocacy #PatientVoice #HealthcareAccess #HealthcarePodcast #TerumoBCT

Did you know the quality of T cells is critical for a successful cell therapy? It's more than just the count. Watch Mindy Miller discuss the importance of collecting T cells at their peak fitness and preserving their phenotype for optimal cell therapy outcomes. Learn more in our #whitepaper on cellular acquisitions for optimal starting material: https://bit.ly/3QA8Qo2 #celltherapy #cellcollection #biomanufacturing #pharma #lifesciences #Tcells #immunology #InnovationandQuality

“At a moment when medication therapy for sickle cell disease (SCD) leaves too many behind and widespread access to curative gene therapies still lies in the distant future, automated red blood cell exchange is experiencing renewed interest. To improve patients’ lives, a broad commitment is needed to expand access to transfusion therapies.” Read the full article in MedCityNews by Koenraad Dierick, MBA, our VP of Patient Access. Koenraad leads a global team of experts in government affairs, medical affairs, and market access, all focused on removing barriers that prevent patients from receiving the care they need: https://lnkd.in/gHHA_54t Join the conversation on how we can improve access to care for SCD patients by following us on LinkedIn, Facebook, and X. LinkedIn: https://bit.ly/4imsQX4 Facebook: https://bit.ly/41CAzum X: https://bit.ly/3QKblUS #SickleCellAwareness #HealthcareAdvancement #PatientAccess #TransfusionTherapy #MedicalAdvocacy #TerumoBCT

Recently, our President & CEO, Antoinette Gawin, and Global Commerical SVP, Cindy Ng, visited Mexico for a day filled with idea-sharing, leadership, and connection with our Latin America team and strategic partners. The day began with a meeting alongside our Functional and Commercial Leadership Team, where Antoinette shared her vision, life experiences, and insights on achieving a balance between personal and professional life. During the Town Hall, Antoinette reinforced Terumo BCT’s commitment to innovation and making a positive impact on healthcare by presenting our global strategy and values. In the afternoon, Antoinette opened a meeting with our distributors, Manlio Fabio Lopez, Country Manager in Mexico, expressed gratitude for their collaboration, and Cindy closed with a toast in recognition of their work. The day then ended with a tour of the Terumo Medical Training Center, reaffirming our commitment to excellence. We are grateful to everyone who made this enriching day possible. As we reflect on leadership and progress, let’s continue driving the future of healthcare—together. #TerumoBCT #Leadership #Innovation #TownHallMexico #IWD2025 #WomenInLeadership #InspiringChange

Two weeks ago, Terumo BCT reached a significant milestone. We hosted our first LinkedIn Live event, attracting viewers from across the globe and various professions, including healthcare administrators, marketing professionals, scientists, advocates, policy makers, and CEOs. Participants joined us from Tanzania, Kenya, India, Egypt, the UK, the US, France, Brazil, Spain, Scotland, and more—spanning five continents. Our speakers shared powerful and humbling insights about living with Sickle Cell Disease (SCD) and the current state of SCD treatments in the healthcare industry. We are deeply grateful to Kevin Wake, M.S., CHW, for sharing his journey with SCD and his determination to receive regular treatments within specific timeframes. His story reminded us and our attendees of the daily battles many face, often greater than our own. Witnessing individuals like Kevin pursue a life filled with joy despite obstacles inspires us at Terumo BCT to continue advocating for patient care and accessible treatments for blood disorders. We extend our heartfelt thanks to Mason Barrett from National Organization for Rare Disorders (NORD) for highlighting resources to support rare diseases and for his unwavering commitment to advancing this mission despite current challenges. We also thank Jackie Kunzler for contributing to this important conversation and for leading discussions on critical topics related to healthcare advancement and access. Lastly, we are grateful to everyone who tuned in to this conversation. Your efforts in spreading awareness within your networks help us make a positive impact on many lives. Thank you. If you missed the Rare Disease Day LinkedIn Live, you can watch it here: https://bit.ly/4kq1YXM #SickleCellAwareness #SCDWarrior #HealthcareAccess #PatientAdvocacy #TerumoBCT #TerumoBloodandCellTechnologies

Building an inclusive culture can’t be done by creating policies or posting statements online—it comes from valuing and appreciating our colleagues’ lived experiences. While leadership plays a role in setting priorities, real inclusion happens by living your Core Values. At Terumo Blood and Cell Technologies, these values shape the conversations we choose to have, the respect we show to each other, and the care we demonstrate to our colleagues and the patients we serve. The power of inclusion lies in individual actions. It’s how we listen, how we seek and appreciate different perspectives, and how we ensure every person feels valued and heard. Creating a culture where people can bring their whole, authentic selves to work isn’t just an initiative on a website—it’s a collective responsibility we bring to team meetings, company events and hallway conversations. Inclusion can't be mandated from the top-down; it has to be built from the ground up. Our entire business thrives when we make space for each other, when we challenge biases (our own and those around us) and when we choose curiosity over assumption. I'm proud to work for Terumo Blood and Cell Technologies, where we continue to prioritize this through our leaders and champions, enabled by a Center of Excellence within our HR organization led by Jessie Rowe and her team. So as we approach International Women's Day this weekend, let’s continue to do the work—not just in words, but in actions. Because inclusion isn’t about a program. It’s about our habits and actions everyday.  #IWD #AccelerateAction #TerumoProud

Terumo DE&I Week starts today, and we kick it off with a message from Chief Executive Officer Hikaru Samejima, who reflects on his personal practice of DE&I and its importance in driving growth and corporate value. Our CEO believes that the active participation of diverse talents is the foundation of the company’s success. In his practice of #DEI, he is committed to inclusive leadership, ensuring that diverse associates can bring their authentic selves and voices to the discussion.  DE&I Week is an annual event across the Terumo Group, bringing us together to celebrate and promote #diversity, #equity, and #inclusion throughout our organization. It’s an opportunity to deepen our understanding, foster an inclusive culture, and strengthen our unity. Let’s continue to build a workplace where everyone can thrive.

Ever faced the challenge of platelet clumping during cell collection? It’s a common hurdle for professionals in the biopharma and biotech industries, but there’s a way to overcome it. Watch Sara Lewandowski explain more about clumping and how Terumo Blood and Cell Technologies can help optimize collection procedures to achieve desired purity levels – and other desired manufacturing or #apheresiscollection characteristics. Learn more about overcoming the challenges of platelet clumping and optimizing the cell collection process in our #whitepaper: https://bit.ly/3QA8Qo2 #CellTherapy #Biopharma #Biotech #CellManufacturing #Apheresis #DataAnalytics #InnovationandQuality